(Q51358606)

English

FDA perspectives on pharmacogenetic testing

scientific article published in September 2005

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16149867

retrieved

4 April 2018

reference URL

http://europepmc.org/abstract/MED/16149867

title

FDA perspectives on pharmacogenetic testing (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16149867

retrieved

4 April 2018

reference URL

http://europepmc.org/abstract/MED/16149867

author name string

Courtney C Harper

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16149867

retrieved

4 April 2018

reference URL

http://europepmc.org/abstract/MED/16149867

Reena Philip

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16149867

retrieved

4 April 2018

reference URL

http://europepmc.org/abstract/MED/16149867

Max Robinowitz

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16149867

retrieved

4 April 2018

reference URL

http://europepmc.org/abstract/MED/16149867

Steven I Gutman

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16149867

retrieved

4 April 2018

reference URL

http://europepmc.org/abstract/MED/16149867

publication date

1 September 2005

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16149867

retrieved

4 April 2018

reference URL

http://europepmc.org/abstract/MED/16149867

published in

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16149867

retrieved

4 April 2018

reference URL

http://europepmc.org/abstract/MED/16149867

volume

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16149867

retrieved

4 April 2018

reference URL

http://europepmc.org/abstract/MED/16149867

issue

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16149867

retrieved

4 April 2018

reference URL

http://europepmc.org/abstract/MED/16149867

page(s)

643-648

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16149867

retrieved

4 April 2018

reference URL

http://europepmc.org/abstract/MED/16149867

cites work

Translation of pharmacogenomics and pharmacogenetics: a regulatory perspective

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2F14737159.5.5.643

retrieved

21 January 2018

Identifiers

DOI

10.1586/14737159.5.5.643

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16149867

retrieved

4 April 2018

reference URL

http://europepmc.org/abstract/MED/16149867

PubMed publication ID

16149867

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16149867

retrieved

4 April 2018

reference URL

http://europepmc.org/abstract/MED/16149867

(Q51358606)

FDA perspectives on pharmacogenetic testing

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)